Literature DB >> 3747335

Adult-onset minimal change nephrotic syndrome: a long-term follow-up.

F Nolasco, J S Cameron, E F Heywood, J Hicks, C Ogg, D G Williams.   

Abstract

A series of 89 adult-onset nephrotic patients with minimal changes on renal biopsy was analyzed to compare the rate of response to corticosteroids and cytotoxic agents and the stability of remission or frequency of relapses at different ages. Severe hypertension and diminished renal function were more common in patients aged over 60 years, who formed 22.5% of the group. Seventy-five patients were given a first course of prednisolone in an initial dose of 60 mg/24 hr. After an eight week course of tapering doses of corticosteroids, only 45 of the 75 patients were in complete remission, 55 patients after 16 weeks and eventually 58 lost their proteinuria. The respective estimates of remission were 60%, 76% and 81%. Subsequently, of the 58 treated patients who responded, 24% never relapsed. Fifty-six percent of the patients relapsed on a single occasion or infrequently, and only 21% were frequent relapsers. Cyclophosphamide was used in 36 patients, in two as initial treatment, in 11 because of corticosteroid resistance, and in the remainder because of relapses. The time-course of loss of proteinuria was similar to that following treatment with corticosteroids, 25 (69%) losing proteinuria within 16 weeks. Only four patients failed to lose their nephrotic syndrome. Two of them had presented in acute renal failure and all four were over 60 years of age. The stability of remission after cyclophosphamide was better than that reported for children, only 13 of 36 showing relapses and 66% being in remission at five years, after which no further relapses were seen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3747335     DOI: 10.1038/ki.1986.130

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  47 in total

1.  Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient.

Authors:  Benjamin D Humphreys; Vijay K Vanguri; Joel Henderson; Joseph H Antin
Journal:  Nat Clin Pract Nephrol       Date:  2006-09

2.  The characteristics of relapse in adult-onset minimal-change nephrotic syndrome.

Authors:  Takashi Takei; Minako Koike; Koichi Suzuki; Satsuki Shirota; Mitsuyo Itabashi; Shigeru Ohtsubo; Hidekazu Sugiura; Keiko Suzuki; Chiari Kojima; Masaki Takahashi; Jun Ino; Tetsuya Ogawa; Keiko Uchida; Ken Tsuchiya; Wako Yumura; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

3.  Treatment aspects of primary nephrotic syndrome in adults.

Authors:  Senija Rasić; Snjezana Uncanin; Jasminka Dzemidzić; Kenana Aganović; Amira Srna; Ismar Rasić
Journal:  Bosn J Basic Med Sci       Date:  2006-05       Impact factor: 3.363

4.  Management of Adult Minimal Change Disease.

Authors:  Stephen M Korbet; William L Whittier
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-05       Impact factor: 8.237

5.  Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury.

Authors:  Eijin Ashikaga; Susumu Uda; Kazuhisa Kamata; Yasuto Shikida; Takashi Inoue; Yoshihiro Kuno; Atsushi Yao; Mari Nakamura; Keiko Kai
Journal:  CEN Case Rep       Date:  2016-03-25

6.  Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Susumu Oseto; Daisuke Mori; Kodo Tomida; Terumasa Hayashi; Masaaki Izumi; Megumu Fukunaga; Atsushi Yamauchi; Yoshiharu Tsubakihara; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2013-03-20       Impact factor: 2.801

7.  [41-year-old female patient with ST-elevation myocardial infarction and multiple arterial emboli].

Authors:  J Bramstedt; J Schröder; R Dissmann
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

8.  American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.

Authors:  Fernando C Fervenza; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

Review 9.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

Review 10.  [Treatment of glomerulonephritis].

Authors:  T Risler; N Braun; C M Erley
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.